Cargando…
PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption
Multiple sclerosis (MS) is a complex disease with an unknown etiology and has no effective medications despite extensive research. Antioxidants suppress oxidative damages which are implicated in the pathogenesis of MS. In this study, we showed that the expression of an antioxidant protein peroxiredo...
Autores principales: | Yun, Hyung-Mun, Park, Kyung-Ran, Kim, Eun-Cheol, Hong, Jin Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673236/ https://www.ncbi.nlm.nih.gov/pubmed/26327204 |
Ejemplares similares
-
Biomarkers Indicative of Blood-Brain Barrier Disruption in Multiple Sclerosis
por: Waubant, Emmanuelle
Publicado: (2006) -
Contribution of Tissue Inflammation and Blood-Brain Barrier Disruption to Brain Softening in a Mouse Model of Multiple Sclerosis
por: Silva, Rafaela Vieira, et al.
Publicado: (2021) -
Peripheral serotonin-mediated system suppresses bone development and regeneration via serotonin 6 G-protein-coupled receptor
por: Yun, Hyung-Mun, et al.
Publicado: (2016) -
Sulfuretin promotes osteoblastic differentiation in primary cultured osteoblasts and in vivo bone healing
por: Auh, Q-Schick, et al.
Publicado: (2016) -
Reviewing the Significance of Blood–Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment
por: Balasa, Rodica, et al.
Publicado: (2021)